Recrudescent meibomian gland carcinoma treated with Xeloda: case report.
Eur J Ophthalmol 2013;
24:279-81. [PMID:
24170512 DOI:
10.5301/ejo.5000367]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/27/2013] [Indexed: 11/20/2022]
Abstract
PURPOSE
To observe the curative effect of Xeloda in meibomian gland carcinoma.
METHODS
We treated a 53-year-old woman, who had recrudescent meibomian gland carcinoma, with Xeloda.
RESULTS
The mass was much smaller with decreased amount of overflow pus after 4 cycles of chemotherapy with Xeloda.
CONCLUSIONS
Xeloda played a significant role in treating recrudescent meibomian gland carcinoma in this patient.
Collapse